At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Market Closed 02-20 16:00:00 EST
9.22
-0.47
-4.85%
盘后9.23
+0.01+0.10%
19:51 EST
High9.65Low9.14Vol642.34K
Open9.55D1 Closing9.69Amplitude5.26%
Mkt Cap558.64MTradable Cap382.97MTotal Shares60.59M
T/O5.99MT/O Rate1.55%Tradable Shares41.54M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ginkgo Bioworks Holdings Inc. published an update to their financial calendar
Reuters  ·  02-19
Ginkgo Bioworks Holdings Inc. published an update to their financial calendar
Ginkgo Bioworks and Invaio Sciences partner to develop peptide crop protection manufacturing strains
Reuters  ·  02-18
Ginkgo Bioworks and Invaio Sciences partner to develop peptide crop protection manufacturing strains
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-Based Agricultural Products
THOMSON REUTERS  ·  02-18
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-Based Agricultural Products
Deep Analysis | The Ingrained Cultural Imperative of Chinese New Year Homecomings
Deep News  ·  02-15
Deep Analysis | The Ingrained Cultural Imperative of Chinese New Year Homecomings
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
GlobeNewswire  ·  02-12
Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth
4basebio Directors Lift Stakes in Synthetic DNA Specialist
TIPRANKS  ·  02-12
4basebio Directors Lift Stakes in Synthetic DNA Specialist
The Safety DNA: Decoding UL 9540B's Unseen Protections
prnewswire  ·  02-11
The Safety DNA: Decoding UL 9540B's Unseen Protections
Ginkgo Bioworks jumps after OpenAI comment on working together
TIPRANKS  ·  02-06
Ginkgo Bioworks jumps after OpenAI comment on working together
Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus
Simply Wall St.  ·  02-04
Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus
Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina
MT Newswires Live  ·  02-02
Pacific Biosciences of California Closes $48.1 Million Sale of DNA Sequencing Assets to Illumina
Guardant reports publication of circulating tumor DNA for MRD detection study
TIPRANKS  ·  02-02
Guardant reports publication of circulating tumor DNA for MRD detection study
MGI Tech to Purchase Entire Stakes in Gene Imaging, DNA/RNA Sequencing Companies
MT Newswires Live  ·  02-02
MGI Tech to Purchase Entire Stakes in Gene Imaging, DNA/RNA Sequencing Companies
Sonim Technologies Rebrands as DNA X, Shifts Strategy
TIPRANKS  ·  01-28
Sonim Technologies Rebrands as DNA X, Shifts Strategy
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
InvestorPlace  ·  01-27
The Genesis Mission Has a 270-Day Timeline – And You’re Already Late
Ginkgo Bioworks CEO to Present at J.P. Morgan Healthcare Conference
Reuters  ·  01-13
Ginkgo Bioworks CEO to Present at J.P. Morgan Healthcare Conference
Converge Bio Secures $25 Million Funding with Backers Including Bessemer Ventures and Executives from Meta, OpenAI, and Wiz
Deep News  ·  01-13
Converge Bio Secures $25 Million Funding with Backers Including Bessemer Ventures and Executives from Meta, OpenAI, and Wiz
What Does CEO Pay and Insider Selling Reveal About Twist Bioscience’s (TWST) Synthetic DNA Ambitions?
Simply Wall St.  ·  01-10
What Does CEO Pay and Insider Selling Reveal About Twist Bioscience’s (TWST) Synthetic DNA Ambitions?
U.S. RESEARCH ROUNDUP-Alcoa, BlackRock, Evercore
Reuters  ·  01-08
U.S. RESEARCH ROUNDUP-Alcoa, BlackRock, Evercore
We Think Bumitama Agri (SGX:P8Z) Might Have The DNA Of A Multi-Bagger
Simply Wall St.  ·  01-08
We Think Bumitama Agri (SGX:P8Z) Might Have The DNA Of A Multi-Bagger
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
GlobeNewswire  ·  01-06
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--